ARCOSA INC (ACA) Fundamental Analysis & Valuation

NYSE:ACA • US0396531008

107.13 USD
-3.19 (-2.89%)
At close: Mar 12, 2026
107.13 USD
0 (0%)
After Hours: 3/12/2026, 5:05:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ACA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall ACA gets a fundamental rating of 5 out of 10. We evaluated ACA against 56 industry peers in the Construction & Engineering industry. Both the profitability and the financial health of ACA get a neutral evaluation. Nothing too spectacular is happening here. ACA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. ACA Profitability Analysis

1.1 Basic Checks

  • In the past year ACA was profitable.
  • ACA had a positive operating cash flow in the past year.
  • Of the past 5 years ACA 4 years were profitable.
  • Of the past 5 years ACA 4 years had a positive operating cash flow.
ACA Yearly Net Income VS EBIT VS OCF VS FCFACA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

  • The Return On Assets of ACA (2.94%) is comparable to the rest of the industry.
  • ACA has a Return On Equity (5.75%) which is in line with its industry peers.
  • With a Return On Invested Capital value of 4.99%, ACA perfoms like the industry average, outperforming 46.43% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ACA is significantly below the industry average of 17.18%.
  • The 3 year average ROIC (3.99%) for ACA is below the current ROIC(4.99%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.94%
ROE 5.75%
ROIC 4.99%
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ACA Yearly ROA, ROE, ROICACA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • ACA's Profit Margin of 5.25% is fine compared to the rest of the industry. ACA outperforms 62.50% of its industry peers.
  • ACA's Profit Margin has declined in the last couple of years.
  • With a decent Operating Margin value of 10.27%, ACA is doing good in the industry, outperforming 69.64% of the companies in the same industry.
  • ACA's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 21.61%, ACA is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ACA has remained more or less at the same level.
Industry RankSector Rank
OM 10.27%
PM (TTM) 5.25%
GM 21.61%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
ACA Yearly Profit, Operating, Gross MarginsACA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ACA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACA is destroying value.
  • ACA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ACA Yearly Shares OutstandingACA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ACA Yearly Total Debt VS Total AssetsACA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.46 indicates that ACA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ACA (2.46) is comparable to the rest of the industry.
  • ACA has a debt to FCF ratio of 5.03. This is a neutral value as ACA would need 5.03 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 5.03, ACA is doing good in the industry, outperforming 62.50% of the companies in the same industry.
  • ACA has a Debt/Equity ratio of 0.61. This is a neutral value indicating ACA is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ACA (0.61) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.03
Altman-Z 2.46
ROIC/WACC0.51
WACC9.83%
ACA Yearly LT Debt VS Equity VS FCFACA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

  • ACA has a Current Ratio of 2.02. This indicates that ACA is financially healthy and has no problem in meeting its short term obligations.
  • ACA has a Current ratio of 2.02. This is amongst the best in the industry. ACA outperforms 87.50% of its industry peers.
  • ACA has a Quick Ratio of 1.30. This is a normal value and indicates that ACA is financially healthy and should not expect problems in meeting its short term obligations.
  • ACA has a better Quick ratio (1.30) than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.3
ACA Yearly Current Assets VS Current LiabilitesACA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ACA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 48.50% over the past year.
  • Measured over the past years, ACA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.78% on average per year.
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.58%

3.2 Future

  • Based on estimates for the next years, ACA will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.17% on average per year.
  • Based on estimates for the next years, ACA will show a small growth in Revenue. The Revenue will grow by 5.28% on average per year.
EPS Next Y9.06%
EPS Next 2Y11.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.18%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
ACA Yearly Revenue VS EstimatesACA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
ACA Yearly EPS VS EstimatesACA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. ACA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 23.97 indicates a rather expensive valuation of ACA.
  • Based on the Price/Earnings ratio, ACA is valued a bit cheaper than 76.79% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.15, ACA is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 21.97, the valuation of ACA can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, ACA is valued a bit cheaper than the industry average as 69.64% of the companies are valued more expensively.
  • ACA is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.97
Fwd PE 21.97
ACA Price Earnings VS Forward Price EarningsACA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 80.36% of the companies in the same industry are more expensive than ACA, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACA indicates a rather cheap valuation: ACA is cheaper than 85.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.7
EV/EBITDA 13.1
ACA Per share dataACA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.64
PEG (5Y)1.88
EPS Next 2Y11.17%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. ACA Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.18%, ACA is not a good candidate for dividend investing.
  • ACA's Dividend Yield is rather good when compared to the industry average which is at 0.14. ACA pays more dividend than 80.36% of the companies in the same industry.
  • With a Dividend Yield of 0.18, ACA pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

  • The dividend of ACA decreases each year by -0.48%.
  • ACA has been paying a dividend for over 5 years, so it has already some track record.
  • ACA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
ACA Yearly Dividends per shareACA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • 6.66% of the earnings are spent on dividend by ACA. This is a low number and sustainable payout ratio.
DP6.66%
EPS Next 2Y11.17%
EPS Next 3YN/A
ACA Yearly Income VS Free CF VS DividendACA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ACA Dividend Payout.ACA Dividend Payout, showing the Payout Ratio.ACA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ACA Fundamentals: All Metrics, Ratios and Statistics

ARCOSA INC

NYSE:ACA (3/12/2026, 5:05:00 PM)

After market: 107.13 0 (0%)

107.13

-3.19 (-2.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners94.27%
Inst Owner Change-3.24%
Ins Owners1.85%
Ins Owner Change2.68%
Market Cap5.25B
Revenue(TTM)N/A
Net Income(TTM)148.60M
Analysts84.44
Price Target125.66 (17.3%)
Short Float %1.81%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP6.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date04-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.63%
Min EPS beat(2)15.61%
Max EPS beat(2)17.65%
EPS beat(4)3
Avg EPS beat(4)38.79%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)30.62%
EPS beat(12)11
Avg EPS beat(12)32.12%
EPS beat(16)15
Avg EPS beat(16)40.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)11
Avg Revenue beat(16)1.99%
PT rev (1m)-0.48%
PT rev (3m)2.81%
EPS NQ rev (1m)-0.54%
EPS NQ rev (3m)-1.1%
EPS NY rev (1m)-0.12%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 23.97
Fwd PE 21.97
P/S 1.85
P/FCF 16.7
P/OCF 11.19
P/B 2.03
P/tB 5.72
EV/EBITDA 13.1
EPS(TTM)4.47
EY4.17%
EPS(NY)4.88
Fwd EY4.55%
FCF(TTM)6.42
FCFY5.99%
OCF(TTM)9.57
OCFY8.93%
SpS57.77
BVpS52.71
TBVpS18.73
PEG (NY)2.64
PEG (5Y)1.88
Graham Number72.81
Profitability
Industry RankSector Rank
ROA 2.94%
ROE 5.75%
ROCE 6.5%
ROIC 4.99%
ROICexc 5.24%
ROICexgc 8.62%
OM 10.27%
PM (TTM) 5.25%
GM 21.61%
FCFM 11.11%
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.03
Debt/EBITDA 3.04
Cap/Depr 68.36%
Cap/Sales 5.46%
Interest Coverage 250
Cash Conversion 90.74%
Profit Quality 211.71%
Current Ratio 2.02
Quick Ratio 1.3
Altman-Z 2.46
F-Score5
WACC9.83%
ROIC/WACC0.51
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
EPS Next Y9.06%
EPS Next 2Y11.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.58%
Revenue Next Year5.18%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.65%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year135.6%
EBIT Next 3Y38.61%
EBIT Next 5YN/A
FCF growth 1Y5015.62%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y146.35%
OCF growth 3Y44.47%
OCF growth 5Y6.95%

ARCOSA INC / ACA FAQ

Can you provide the ChartMill fundamental rating for ARCOSA INC?

ChartMill assigns a fundamental rating of 5 / 10 to ACA.


Can you provide the valuation status for ARCOSA INC?

ChartMill assigns a valuation rating of 4 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.


How profitable is ARCOSA INC (ACA) stock?

ARCOSA INC (ACA) has a profitability rating of 5 / 10.


What is the valuation of ARCOSA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 23.97 and the Price/Book (PB) ratio is 2.03.


How financially healthy is ARCOSA INC?

The financial health rating of ARCOSA INC (ACA) is 5 / 10.